<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">4344</id>
  <title>T3D4290</title>
  <common-name>Creatine</common-name>
  <description>Creatine is an amino acid that occurs in vertebrate tissues and in urine. In muscle tissue, creatine generally occurs as phosphocreatine. Creatine is excreted as creatinine in the urine. Creatine functions as part of the cell's energy shuttle. The high energy phosphate group of ATP is transferred to creatine to form phosphocreatine in the following reaction: Cr + ATP &lt;-&gt; PCr + ADP. This reaction is reversibly catalyzed by creatine kinase. In the human body creatine is synthesized mainly in the liver by the use of parts from three different amino acids - arginine, glycine, and methionine. 95% of it is later stored in the skeletal muscles, with the rest in the brain, heart, testes.</description>
  <cas>57-00-1</cas>
  <pubchem-id>586</pubchem-id>
  <chemical-formula>C4H9N3O2</chemical-formula>
  <weight nil="true"/>
  <appearance>White powder.</appearance>
  <melting-point>255 dec°C</melting-point>
  <boiling-point></boiling-point>
  <density nil="true"/>
  <solubility>1.33E+004 mg/L (at 18°C)</solubility>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity>In the muscles, a fraction of the total creatine binds to phosphate - forming creatine phosphate. The reaction is catalysed by creatine kinase, and the result is phosphocreatine (PCr). Phosphocreatine binds with adenosine diphosphate to convert it back to ATP (adenosine triphosphate), an important cellular energy source for short term ATP needs prior to oxidative phosphorylation.</mechanism-of-toxicity>
  <metabolism>Half Life: 3 hours</metabolism>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity>No indication of carcinogenicity to humans (not listed by IARC).</carcinogenicity>
  <use-source>For nutritional supplementation, also for treating dietary shortage or imbalance</use-source>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2014-08-29T06:16:04Z</created-at>
  <updated-at type="dateTime">2026-03-31T18:11:25Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia>Creatine</wikipedia>
  <uniprot-id nil="true"/>
  <kegg-compound-id>C00300</kegg-compound-id>
  <omim-id nil="true"/>
  <chebi-id>16919</chebi-id>
  <biocyc-id>CREATINE</biocyc-id>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id>DB00148</drugbank-id>
  <pdb-id>CRN</pdb-id>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CN(CC(O)=O)C(N)=N</moldb-smiles>
  <moldb-formula>C4H9N3O2</moldb-formula>
  <moldb-inchi>InChI=1S/C4H9N3O2/c1-7(4(5)6)2-3(8)9/h2H2,1H3,(H3,5,6)(H,8,9)</moldb-inchi>
  <moldb-inchikey>CVSVTCORWBXHQV-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">131.1332</moldb-average-mass>
  <moldb-mono-mass type="decimal">131.069476547</moldb-mono-mass>
  <origin>Endogenous</origin>
  <state>Solid</state>
  <logp>-0.2</logp>
  <hmdb-id>HMDB00064</hmdb-id>
  <chembl-id>CHEMBL283800</chembl-id>
  <chemspider-id>566</chemspider-id>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference>&lt;p&gt;Stefan Weiss, Helmut Krommer, &amp;#8220;Process for the preparation of a creatine or creatine monohydrate.&amp;#8221; U.S. Patent US5719319, issued September, 1963.&lt;/p&gt;</synthesis-reference>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM003250</chemdb-id>
  <dsstox-id>DTXSID1040451</dsstox-id>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id>NS00009931</susdat-id>
  <iupac>2-(N-methylcarbamimidamido)acetic acid</iupac>
</compound>
